News
Arlington Capital Partners portfolio company AVS Bio has acquired ImmunoPrecise Antibodies Europe (IPA Europe). IPA Europe is a carve-out of ImmunoPrecise Antibodies, a biotherapeutics company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback